----item----
version: 1
id: {0BB69079-EE38-4683-A3EC-F2D6CAB6FB83}
database: master
path: /sitecore/content/Pharma/MedtechInsight/Home/Articles/Mergers and Acquisitions 2014
parent: {D5B965D3-AC3D-4A7F-90E6-65193022C6B5}
name: Mergers and Acquisitions 2014
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----field----
field: {A4F985D9-98B3-4B52-AAAF-4344F6E747C6}
name: __Workflow
key: __workflow
content-length: 38

{926E6200-EB76-4AD4-8614-691D002573AC}
----version----
language: en
version: 1
revision: 5eba67ac-6f37-477c-959d-75fa3a463391

----field----
field: {5BA0578F-65B7-4C22-8233-1603D698D8A4}
name: Summary
key: summary
content-length: 1162

<p>  <tbody> <tr> </tr> <tr> <td> <tbody> <tr> <td>The latest medtech deals, as and when it happens<a></a><br> <em>By Madeleine Armstrong, Editor, Business</em><br> In order to keep track of the busy medtech mergers and acquisitions market, Clinica brings to you its &lsquo;live&rsquo; M&amp;A table. Featuring the latest transactions in the medical device arena, the table features all pending and closed deals of 2012 so far. </td> </tr> <tr> <td><strong>M&amp;A 2014</strong></td> <td><a><strong>M&amp;A 2013</strong></a></td> <td><strong><a>M&amp;A 2012</a></strong></td> <td><strong><a>FREE TRIAL</a></strong></td> </tr> </tbody> </td> </tr> <tr> <td><a></a></td> <td><div><a></a></div></td> <td><a></a></td> <td><div><a></a></div></td> <td><a></a></td> <td><a></a></td> <td><a></a></td> <td><a></a></td> </tr> <tr> <td><div><a>Deals</a></div></td> <td><div><a>M&amp;A </a></div></td> <td><div><a>Financials</a></div></td> <td><div><a>Funding </a></div></td> <td><div><a>Legal</a></div></td> <td><div><a>Start-ups &amp; SMEs </a></div></td> <td><div><a>Market Monitor </a></div></td> <td><div><a>Google Map: M&amp;A 2010 </a></div></td> </tr> </tbody>  </p>
----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 29

Mergers and Acquisitions 2014
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 89145

<p> <table> <tbody> <tr> </tr> <tr> <td colspan="8" scope="row" widtd="101"><table> <tbody> <tr> <td colspan="4" scope="row" widtd="101">The latest medtech deals, as and when it happens<a name="top" id="top"></a><br> <em>By Madeleine Armstrong, Editor, Business</em><br> In order to keep track of the busy medtech mergers and acquisitions market, Clinica brings to you its &lsquo;live&rsquo; M&amp;A table. Featuring the latest transactions in the medical device arena, the table features all pending and closed deals of 2012 so far. </td> </tr> <tr> <td bgcolor="#cccccc" scope="row" widtd="101"><strong>M&amp;A 2014</strong></td> <td bgcolor="#666666" scope="row" widtd="101"><a href="http://www.clinica.co.uk/MnA/_2013/" class="optionsLink"><strong>M&amp;A 2013</strong></a></td> <td bgcolor="#666666" scope="row" widtd="101"><strong><a href="http://www.clinica.co.uk/MnA/_2012/" class="optionsLink">M&amp;A 2012</a></strong></td> <td bgcolor="#666666" scope="row" widtd="101"><strong><a href="http://www.clinica.co.uk/freetrial/" class="optionsLink">FREE TRIAL</a></strong></td> </tr> </tbody> </table></td> </tr> <tr> <td><a href="http://www.clinica.co.uk/business/"><img src="-/media/A41DB0E6789340E3BBE2BB586EBE4293.ashx" alt="Deals" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> <td scope="row" widtd="101"><div><a href="http://www.clinica.co.uk/business/manda/"><img src="-/media/1594690D6C314ABFA668C2F281D90DEC.ashx" alt="M&amp;A" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></div></td> <td><a href="http://www.clinica.co.uk/business/financials/"><img src="-/media/873669F6772642DC9C0C091A39B44486.ashx" alt="Financials" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> <td><div><a href="http://www.clinica.co.uk/business/funding/"><img src="-/media/B1AB1227A20C433897DB3C8B2F140E45.ashx" alt="Funding" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></div></td> <td><a href="http://www.clinica.co.uk/business/legal/"><img src="-/media/7D0516FC157A4E1F896F543962188904.ashx" alt="Legal" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> <td><a href="http://www.clinica.co.uk/business/start-upssmes/"><img src="-/media/66EE0878ED2E4CEC9D21449351C40077.ashx" alt="Start-ups &amp; SMEs" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> <td><a href="http://www.clinica.co.uk/business/marketmonitor/"><img src="-/media/808B4B2204F542438455FA3DB83F4C28.ashx" alt="Market Monitor" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> <td><a href="http://www.clinica.co.uk/ma2/"><img src="-/media/7183F022AB364B8C8C43E7EC13518288.ashx" alt="Google Map" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> </tr> <tr> <td scope="row" widtd="101"><div><a href="http://www.clinica.co.uk/business/" class="optionsLink">Deals</a></div></td> <td scope="row" widtd="101"><div><a href="http://www.clinica.co.uk/business/manda/" class="optionsLink">M&amp;A </a></div></td> <td><div><a href="http://www.clinica.co.uk/business/financials/" class="optionsLink">Financials</a></div></td> <td><div><a href="http://www.clinica.co.uk/business/funding/" class="optionsLink">Funding </a></div></td> <td><div><a href="http://www.clinica.co.uk/business/legal/" class="optionsLink">Legal</a></div></td> <td><div><a href="http://www.clinica.co.uk/business/start-upssmes/" class="optionsLink">Start-ups &amp; SMEs </a></div></td> <td><div><a href="http://www.clinica.co.uk/business/marketmonitor/" class="optionsLink">Market Monitor </a></div></td> <td><div><a href="http://www.clinica.co.uk/ma2/" class="optionsLink">Google Map: M&amp;A 2010 </a></div></td> </tr> </tbody> </table> </p> <p><p> <table> <tr> <th bgcolor="#C5E2E2" scope="col"> <p> <b>Acquirer </b> </p> </th> <th bgcolor="#C5E2E2" scope="col"> <p> <b>Target </b> </p> </th> <th bgcolor="#C5E2E2" scope="col"> <p> <b>Industry sector </b> </p> </th> <th bgcolor="#C5E2E2" scope="col"> <p> <b>Price paid </b> </p> </th> <th bgcolor="#C5E2E2" scope="col"> <p> <b>Date announced </b> </p> </th> <th bgcolor="#C5E2E2" scope="col"> <p> <b>Date completed </b> </p> </th> </tr> <tr> <td> <p> <b>2014</b> </p> </td> <td> <p> <b> </b> </p> </td> <td> <p> <b> </b> </p> </td> <td> <p> <b> </b> </p> </td> <td> <p> <b> </b> </p> </td> <td> <p> <b> </b> </p> </td> </tr> <tr> <td> <p> <b>December</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Alternative Energy &amp; Environmental Solutions (US)</b> </p> </td> <td> <p> BioTechPharma (US) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 22/12/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Uroplasty (US)</b> </p> </td> <td> <p> Vision-Sciences (US) </p> </td> <td> <p> Urology </p> </td> <td> <p> Stock-based deal </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/New-player-on-the-urology-block-with-Uroplasty-Vision-Sciences-merger-355836?autnID=/contentstore/clinica/codex/fc191c28-8a9d-11e4-9472-f1990ec59256.xml">22/12/14 </a> </p> </td> <td> <p> 31/3/15 </p> </td> </tr> <tr> <td> <p> <b>ZOLL Medical (US)</b> </p> </td> <td> <p> Advanced Circulatory Systems (US) </p> </td> <td> <p> Cardiology </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Zoll-gets-circulation-boosting-tech-with-Advanced-Circulatory-Systems-buy-355811?autnID=/contentstore/clinica/codex/a7c251d6-8a89-11e4-9472-f1990ec59256.xml">22/12/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>JunoPacific (US)</b> </p> </td> <td> <p> Lawrence Tool and Engineering (US) </p> </td> <td> <p> Medical device production </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 22/12/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Roche (Switzerland)</b> </p> </td> <td> <p> Bina Technologies (US) </p> </td> <td> <p> Genomic informatics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Roche-moves-into-genomics-informatics-with-Bina-buy-355792?autnID=/contentstore/clinica/codex/20069db4-89c3-11e4-9472-f1990ec59256.xml">19/12/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Minebea (Japan)</b> </p> </td> <td> <p> Sartorius' Industrial Technologies Division (Germany) </p> </td> <td> <p> Lab products and bioprocessing </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 19/12/14 </p> </td> <td> <p> 9/2/15 </p> </td> </tr> <tr> <td> <p> <b>Machine Solutions (US)</b> </p> </td> <td> <p> Steeger USA (US) </p> </td> <td> <p> Medical device manufacturing </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 18/12/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Varian Medical Systems (US)</b> </p> </td> <td> <p> MeVis Medical Solutions (Germany) </p> </td> <td> <p> Diagnostic imaging software </p> </td> <td> <p> &euro;30m ($36m) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Varian-bolsters-imaging-offering-with-software-specialist-MeVis-355728?autnID=/contentstore/clinica/codex/da851a32-86a1-11e4-9472-f1990ec59256.xml">17/12/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Philips (the Netherlands)</b> </p> </td> <td> <p> Volcano (US) </p> </td> <td> <p> Cardiovascular / image -guided therapy </p> </td> <td> <p> &euro;800m ($1bn) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Philips-splashes-1bn-on-Volcano-355710?autnID=/contentstore/clinica/codex/b54c43e3-85e0-11e4-9472-f1990ec59256.xml">17/12/14</a> </p> </td> <td> <p> 17/2/15 </p> </td> </tr> <tr> <td> <p> <b>Patterson Companies (US)</b> </p> </td> <td> <p> Holt Dental Supply (US) </p> </td> <td> <p> Dental services </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/MnA-round-up-Baxter-offloads-more-vaccines-Patterson-and-Eastern-Company-strike-deals-355682">15/12/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>The Eastern Company (US)</b> </p> </td> <td> <p> Argo Transdata (US) </p> </td> <td> <p> Medical device components </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/MnA-round-up-Baxter-offloads-more-vaccines-Patterson-and-Eastern-Company-strike-deals-355682">15/12/14</a> </p> </td> <td> <p> 15/12/14 </p> </td> </tr> <tr> <td> <p> <b>Nanotherapeutics (US)</b> </p> </td> <td> <p> Baxter International's Vero cell technology (US) </p> </td> <td> <p> Vaccines platform </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/MnA-round-up-Baxter-offloads-more-vaccines-Patterson-and-Eastern-Company-strike-deals-355682">15/12/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Roche Diagnostics (Switzerland)</b> </p> </td> <td> <p> AvanSci Bio's tissue dissection technology (US) </p> </td> <td> <p> Molecular diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/MnA-round-up-Welch-Allyn-bags-telehealth-firm-Roche-gets-tissue-dissection-tech-355568?autnID=/contentstore/clinica/codex/82e74d85-8124-11e4-9472-f1990ec59256.xml">10/12/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Synergetics (US)</b> </p> </td> <td> <p> Sterimedix (UK) </p> </td> <td> <p> Ophthalmology and aesthetics </p> </td> <td> <p> $13.5m </p> </td> <td> <p> 10/12/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Welch Allyn (US)</b> </p> </td> <td> <p> HealthInterlink (US) </p> </td> <td> <p> Telehealth </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/MnA-round-up-Welch-Allyn-bags-telehealth-firm-Roche-gets-tissue-dissection-tech-355568?autnID=/contentstore/clinica/codex/82e74d85-8124-11e4-9472-f1990ec59256.xml">8/12/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Eurofins Scientific (Belgium)</b> </p> </td> <td> <p> Boston Heart Diagnostics (US) </p> </td> <td> <p> In vitro diagnostics (cardiovascular testing) </p> </td> <td> <p> $140m upfront, $60m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Eurofins-gets-into-cardiology-diagnostics-with-Boston-Heart-buy-355546?autnID=/contentstore/clinica/codex/fa19f86c-805c-11e4-9472-f1990ec59256.xml">8/12/14 </a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Laboratory Corporation of America (LabCorp, US)</b> </p> </td> <td> <p> SolutionPoint International's Bode Technology Group (US) </p> </td> <td> <p> Forensic DNA testing </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/MnA-round-up-LabCorp-bags-Bode-Alphaeon-makes-Clarion-call-355498?autnID=/contentstore/clinica/codex/d7e3d140-7ef0-11e4-9472-f1990ec59256.xml">5/12/14 </a> </p> </td> <td> <p> 5/12/14 </p> </td> </tr> <tr> <td> <p> <b>BTG (UK)</b> </p> </td> <td> <p> PneumRx (US) </p> </td> <td> <p> Interventional pulmonology </p> </td> <td> <p> $230m upfront, $245 milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/BTG-enters-pulmonology-market-with-PneumRx-buy-355444">4/12/14</a> </p> </td> <td> <p> 7/1/15 </p> </td> </tr> <tr> <td> <p> <b>Ridgemont Equity Partners (US)</b> </p> </td> <td> <p> Allied 100 (US) </p> </td> <td> <p> Cardiology (automated external defibrillators) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 3/12/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Roche (Switzerland)</b> </p> </td> <td> <p> Ariosa Diagnostics (US) </p> </td> <td> <p> Molecular diagnostics (noninvasive prenatal testing) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/One-in-the-eye-for-Illumina-as-Roche-buys-prenatal-test-maker-355371">2/12/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>November</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Collagen Solutions (UK)</b> </p> </td> <td> <p> Southern Lights Biomaterials (New Zealand) </p> </td> <td> <p> Biomaterials </p> </td> <td> <p> NZ$12m ($9.4m) </p> </td> <td> <p> 21/11/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Abaxis (US)</b> </p> </td> <td> <p> QCR &amp; Trio Diagnostics (UK) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 21/11/14 </p> </td> <td> <p> 17/11/14 </p> </td> </tr> <tr> <td> <p> <b>Kelyniam Global (US)</b> </p> </td> <td> <p> MED-ALLY (US) </p> </td> <td> <p> Neuromodulation </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 19/11/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>iKang Healthcare Group (China)</b> </p> </td> <td> <p> Three medical centers from Ciming Checkup Group (China) </p> </td> <td> <p> Medical centers </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 19/11/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>SWM (US)</b> </p> </td> <td> <p> Certain assets from Smith &amp; Nephew's Advanced Wound Management division (UK) </p> </td> <td> <p> Wound care </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/JEFFERIES-2014-SNN-targets-high-growth-sectors-as-acquisition-talk-fades-355198?autnID=/contentstore/clinica/codex/10409025-7170-11e4-bed5-63485ace4170.xml">19/11/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>CoorsTek Medical (US)</b> </p> </td> <td> <p> Nanosurfaces Industries (Italy) </p> </td> <td> <p> Orthopedics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 18/11/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>ZOLL Medical (US)</b> </p> </td> <td> <p> Philips' InnerCool business (US) </p> </td> <td> <p> Temperature management for emergency care </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Zoll-buys-Philips-InnerCool-biz-355252">17/11/14 </a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Actavis (US)</b> </p> </td> <td> <p> Allergan (US) </p> </td> <td> <p> Pharmaceuticals and aesthetic devices </p> </td> <td> <p> $66bn cash &amp; stock </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Big-paydays-all-around-in-Actaviss-66bn-Allergan-purchase-355118?autnID=/contentstore/clinica/codex/6fcfcd1b-6f25-11e4-bed5-63485ace4170.xml">17/11/14</a> </p> </td> <td> <p> 17/3/15 </p> </td> </tr> <tr> <td> <p> <b>Valeant Pharmaceuticals International (Canada)</b> </p> </td><td> <p> Nicox's ophthalmic diagnostics unit (US) </p> </td> <td> <p> Ophthalmology diagnostics </p> </td> <td> <p> $10m upfront, up to $10m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Nicox-sells-ophthalmic-Dx-unit-to-Valeant-sharpens-focus-on-therapeutics-355104?autnID=/contentstore/clinica/codex/0069f3e8-6e75-11e4-bed5-63485ace4170.xml">17/11/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Fresenius Medical Care (Germany)</b> </p> </td> <td> <p> Cogent Healthcare (US) </p> </td> <td> <p> Hospital services </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 13/11/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Truven Health Analytics (US)</b> </p> </td> <td> <p> Heartbeat Experts (US) </p> </td> <td> <p> Healthcare analytics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 12/11/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>EQT (UK)</b> </p> </td> <td> <p> Siemens Audiology Solutions (Germany) </p> </td> <td> <p> Hearing aids </p> </td> <td> <p> $2.67bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/financials/Siemens-hears-sweet-music-with-2.15bn-deal-for-Audiology-sees-Dx-profit-jump-for-Q4-354927?autnID=/contentstore/clinica/codex/c752fffd-6680-11e4-bed5-63485ace4170.xml">7/11/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Global Healthcare Exchange (US)</b> </p> </td> <td> <p> Vendormate (US) </p> </td> <td> <p> IT (healthcare supply chain) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 6/11/14 </p> </td> <td> <p> 20/11/14 </p> </td> </tr> <tr> <td> <p> <b>SV Life Sciences (US)</b> </p> </td> <td> <p> Majority stake in Ximedica (US) </p> </td> <td> <p> Medical device development </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 5/11/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Cardio3 BioSciences (Belgium)</b> </p> </td> <td> <p> CorQuest Medical (US) </p> </td> <td> <p> Cardiovascular (heart surgery) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Cardio3-diversifies-with-novel-heart-access-technology-platform-354873?autnID=/contentstore/clinica/codex/5285b048-6511-11e4-bed5-63485ace4170.xml">5/11/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Vitrolife (Sweden)</b> </p> </td> <td> <p> FertiliTech (Denmark) </p> </td> <td> <p> Assisted reproduction </p> </td> <td> <p> 1.9m shares </p> </td> <td> <p> 4/11/14 </p> </td> <td> <p> 26/11/14 </p> </td> </tr> <tr> <td> <p> <b>Cantel Medical (US)</b> </p> </td> <td> <p> International Medical Service (Italy) </p> </td> <td> <p> Sterilization/reprocessing </p> </td> <td> <p> &euro;19.6m ($24.5m) </p> </td> <td> <p> 4/11/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>AstraZeneca's MedImmune unit (US)</b> </p> </td> <td> <p> Definiens (Germany) </p> </td> <td> <p> Molecular diagnostics </p> </td> <td> <p> $150m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Definiens-scooped-up-by-AstraZeneca-354860?autnID=/contentstore/clinica/codex/815ba11a-64ed-11e4-bed5-63485ace4170.xml">4/11/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>PDI (US)</b> </p> </td> <td> <p> RedPath Integrated Pathology (US) </p> </td> <td> <p> Molecular diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 3/11/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>LabCorp (US)</b> </p> </td> <td> <p> Covance (US) </p> </td> <td> <p> Clinical research </p> </td> <td> <p> $6.1bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/LabCorp-splashes-6bn-on-drug-trial-firm-Covance-354844?autnID=/contentstore/clinica/codex/3bd2beee-6417-11e4-bed5-63485ace4170.xml">3/11/14</a> </p> </td> <td> <p> 19/2/15 </p> </td> </tr> <tr> <td> <p> <b>Spectranetics (US)</b> </p> </td> <td> <p> Covidien's Stellarex drug coated angioplasty balloon (Ireland) </p> </td> <td> <p> Cardiovascular </p> </td> <td> <p> $30m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Spectranetics-bags-Covidiens-drug-coated-balloon-354810?autnID=/contentstore/clinica/codex/13829587-6361-11e4-bed5-63485ace4170.xml">2/11/14</a> </p> </td> <td> <p> 27/1/15 </p> </td> </tr> <tr> <td> <p> <b>October</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Mesa Laboratories (US)</b> </p> </td> <td> <p> ATI Atlas (UK) </p> </td> <td> <p> Sterilzation </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 31/10/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Sterigenics International (US)</b> </p> </td> <td> <p> Gammarad (Italy) </p> </td> <td> <p> Sterilization </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 31/10/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Abbott (US)</b> </p> </td> <td> <p> Topera (US) </p> </td> <td> <p> Cardiovascular </p> </td> <td> <p> $250m upfront plus undisclosed milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Abbott-enters-electrophysiology-fray-with-Topera-ACT-deals-354750">29/10/14</a> </p> </td> <td> <p> 22/12/14 </p> </td> </tr> <tr> <td> <p> <b>Creganna-Tactx Medical (Ireland)</b> </p> </td> <td> <p> Precision Wire Components (US) </p> </td> <td> <p> Wire components for medical devices </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 29/10/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Optum (US)</b> </p> </td> <td> <p> Alere's Alere Health business (US) </p> </td> <td> <p> Health services </p> </td> <td> <p> $600m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Alere-continues-refocus-with-health-services-sale-in-spite-of-tough-Q3-354736">28/10/14</a> </p> </td> <td> <p> 9/1/15 </p> </td> </tr> <tr> <td> <p> <b>Danaher/ Leica Biosystems (US/UK)</b> </p> </td> <td> <p> Devicor Medical (US) </p> </td> <td> <p> Breast biopsy instruments </p> </td> <td> <p> Undisclosed ($550m estimated) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Danahers-Leica-moves-into-breast-biopsy-arena-with-Devicor-buy-354737">28/10/14</a> </p> </td> <td> <p> 3/12/14 </p> </td> </tr> <tr> <td> <p> <b>ZOLL Medical (US)</b> </p> </td> <td> <p> Impact Instrumentation (US) </p> </td> <td> <p> Respiratory care </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 28/10/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Fujifilm (Japan)</b> </p> </td> <td> <p> Kalon Biotherapeutics (US) </p> </td> <td> <p> Vaccines </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 27/10/14 </p> </td> <td> <p> 18/12/14 </p> </td> </tr> <tr> <td> <p> <b>Wright Medical (US)</b> </p> </td> <td> <p> Tornier (the Netherlands) </p> </td> <td> <p> Orthopedics </p> </td> <td> <p> $3.3bn stock deal </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Wright-and-Tornier-merge-to-form-mid-sized-extremities-player-354716">27/10/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Metalmark Capital (US)</b> </p> </td> <td> <p> Majority stake in Collagen Matrix (US) </p> </td> <td> <p> Regenerative medicine </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 27/10/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Sverica International (US)</b> </p> </td> <td> <p> Resonetics (US) </p> </td> <td> <p> Laser micromachining manufacturing services for medical device and diagnostic companies </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 23/10/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Globus Medical (US)</b> </p> </td> <td> <p> Transplant Technologies (US) </p> </td> <td> <p> Orthopedics/biomaterials </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 23/10/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>OxySure Systems (US)</b> </p> </td> <td> <p> Estill Medical Technologies (US) </p> </td> <td> <p> Emergency medicine </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 22/10/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Eurofins Genomics (Germany)</b> </p> </td> <td> <p> VBC-Biotech oligonucleotide synthesis and DNA sequencing businesses (Austria) </p> </td> <td> <p> Genome sequencing </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 21/10/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Materialise (Belgium)</b> </p> </td> <td> <p> OrthoView Holdings (UK) </p> </td> <td> <p> IT (pre-operative planning software) </p> </td> <td> <p> &pound;8.47m ($13.69), &pound;0.36m ($0.58) milestones </p> </td> <td> <p> 21/10/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Mesa Laboratories (US)</b> </p> </td> <td> <p> Process Challenge Devices' process challenge device business (US) </p> </td> <td> <p> Sterilization </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 15/10/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Breg (US)</b> </p> </td> <td> <p> United Orthopedic Group (US) </p> </td> <td> <p> Orthopedics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 15/10/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Bioventus (US)</b> </p> </td> <td> <p> Advanced Biologics' OsteoAMP product line (US) </p> </td> <td> <p> Orthopedics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 13/10/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Becton Dickinson (US)</b> </p> </td> <td> <p> GenCell Biosystems (Ireland) </p> </td> <td> <p> Next-generation sequencing </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/MnA-round-up-BD-gets-into-next-gen-sequencing-Danaher-casts-off-communications-biz-354441?autnID=/contentstore/clinica/codex/9e6cb3a1-538f-11e4-b346-09673353c40f.xml">13/10/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Steris (US)</b> </p> </td> <td> <p> Synergy Health (UK) </p> </td> <td> <p> Sterilization servces </p> </td> <td> <p> $1.9bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/Steris-buys-Synergy-for-1.9bn-to-create-sterilization-giant-354434">13/10/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Techcomp (Hong Kong)</b> </p> </td> <td> <p> Bruker's Gas Chromatography business (US) </p> </td> <td> <p> Clinical research </p> </td> <td> <p> HK$105.3m ($13.5m) </p> </td> <td> <p> 9/10/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Roche (Switzerland)</b> </p> </td> <td> <p> AbVitro's PETE technology for next-generation genome sequencing </p> </td> <td> <p> Molecular diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 9/10/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>The Cooper Companies (US)</b> </p> </td> <td> <p> EndoSee (US) </p> </td> <td> <p> Women's health </p> </td> <td> <p> $44m </p> </td> <td> <p> 8/10/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Sequenom (US)</b> </p> </td> <td> <p> Noninvasive prenatal testing intellectual property from Isis Innovation (UK) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> $14.55m </p> </td> <td> <p> 6/10/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Becton Dickinson (US)</b> </p> </td> <td> <p> CareFusion (US) </p> </td> <td> <p> Medication management and patient care </p> </td> <td> <p> $12.2bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/BD-and-CareFusion-next-to-merge-in-12.2bn-deal-354305?autnID=/contentstore/clinica/codex/0d60388f-4d41-11e4-b346-09673353c40f.xml">5/10/14 </a> </p> </td> <td> <p> 17/3/15 </p> </td> </tr> <tr> <td> <p> <b>Carlisle Companies (US)</b> </p> </td> <td> <p> LHi Technology (Singapore) </p> </td> <td> <p> Medical device components </p> </td> <td> <p> $195m </p> </td> <td> <p> 2/10/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Immucor (US)</b> </p> </td> <td> <p> Sentilus (US) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 1/10/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Zimmer (US)</b> </p> </td> <td> <p> ETEX Holdings (US) </p> </td> <td> <p> Orthopedics (biologics) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Zimmer-boosts-biologics-with-ETEX-buy-354328?autnID=/contentstore/clinica/codex/bf7edd6d-4a32-11e4-b346-09673353c40f.xml">1/10/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>September</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Waypoint Capital (Switzerland)</b> </p> </td> <td> <p> Euromedic International (Hungary) </p> </td> <td> <p> Advanced diagnostic imaging and cancer care services </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Waypoint-swoops-for-Euromedic-354256?autnID=/contentstore/clinica/codex/1ca593fa-4967-11e4-b346-09673353c40f.xml">30/9/14 </a> </p> </td> <td> <p> 16/12/14 </p> </td> </tr> <tr> <td> <p> <b>Consort Medical (UK)</b> </p> </td> <td> <p> Aesica Pharmaceuticals (UK) </p> </td> <td> <p> Pharmaceutical supply chain (for drug delivery technology) </p> </td> <td> <p> &pound;230m ($372m) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Consort-makes-logical-230m-vertical-integration-move-354216?autnID=/contentstore/clinica/codex/960ead05-48a7-11e4-b346-09673353c40f.xml">30/9/14</a> </p> </td> <td> <p> 12/11/14 </p> </td> </tr> <tr> <td> <p> <b>Laboratory Corporation of America (LabCorp, US)</b> </p> </td> <td> <p> LipoScience (US) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> $63m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/LabCorp-bags-LipoScience-for-63m-354156">25/9/14</a> </p> </td> <td> <p> 21/11/14 </p> </td> </tr> <tr> <td> <p> <b>Specialist Diagnostics Services (Australia)</b> </p> </td> <td> <p> Genetic Technologies' Australian Genetics business (Australia) </p> </td> <td> <p> Diagnostic and genome sequencing services </p> </td> <td> <p> Aus$2m </p> </td> <td> <p> 22/9/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Owens &amp; Minor (US)</b> </p> </td> <td> <p> ArcRoyal (Ireland) </p> </td> <td> <p> Surgery </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 22/9/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>LeMaitre Vascular (US)</b> </p> </td> <td> <p> Applied Medical's angioscope product line (US) </p> </td> <td> <p> Cardiovascular </p> </td> <td> <p> $420,000 </p> </td> <td> <p> 19/9/14 </p> </td> <td> <p> 19/9/14 </p> </td> </tr> <tr> <td> <p> <b>Integra LifeSciences (US)</b> </p> </td> <td> <p> Medtronic's MicroFrance and Xomed manual ENT and laparascopy instrumentation lines (US) </p> </td> <td> <p> Surgery </p> </td> <td> <p> $60m </p> </td> <td> <p> 18/9/14 </p> </td> <td> <p> 27/10/14 </p> </td> </tr> <tr> <td> <p> <b>Bibby Scientific (UK)</b> </p> </td> <td> <p> PCRmax (UK) </p> </td> <td> <p> Diagnostic lab equipment </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 16/9/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>American Liberty Petroleum (US)</b> </p> </td> <td> <p> Avant Diagnostics (US) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 15/9/14 </p> </td> <td> <p> 30/12/14 </p> </td> </tr> <tr> <td> <p> <b>Danaher (US)</b> </p> </td> <td> <p> Nobel Biocare (Switzerland) </p> </td> <td> <p> Dental implants </p> </td> <td> <p> $2.2bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Danaher-splashes-2bn-on-dental-implant-firm-Nobel-353934?autnID=/contentstore/clinica/codex/bfa08ae5-3cc9-11e4-8579-77c2a37f9192.xml">15/9/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Advanced Accelerator Applications (France)</b> </p> </td> <td> <p> GE Healthcareï¿½s Italian FDG-PET imaging agent business (Italy) </p> </td> <td> <p> Diagnostic imaging agents </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/AAA-acquires-GEs-Italian-PET-imaging-business-353820?autnID=/contentstore/clinica/codex/21acbca4-399b-11e4-8579-77c2a37f9192.xml">11/9/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Immunodiagnostic Systems (UK)</b> </p> </td> <td> <p> Diametra (Italy) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Immunodiagnostic-Systems-strengthens-endocrinology-offering-with-Diametra-buy-353793?autnID=/contentstore/clinica/codex/348c5532-38dc-11e4-ab26-2182f8e8159a.xml">10/9/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Argon Medical Devices (US)</b> </p> </td> <td> <p> Promex Technologies (US) </p> </td> <td> <p> Biopsy instruments </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 9/9/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Alphaeon (US)</b> </p> </td> <td> <p> Clarion Medical Technologies (Canada) </p> </td> <td> <p> Aesthetics, ENT, gynecology, vision, urology </p> </td> <td> <p> $55m </p> </td> <td> <p> 8/9/14 </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/MnA-round-up-LabCorp-bags-Bode-Alphaeon-makes-Clarion-call-355498?autnID=/contentstore/clinica/codex/d7e3d140-7ef0-11e4-9472-f1990ec59256.xml">5/12/14</a> </p> </td> </tr> <tr> <td> <p> <b>Breas Medical (Sweden)</b> </p> </td> <td> <p> B &amp; D Electromedical (UK) </p> </td> <td> <p> Medical ventilators and airway clearance devices </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 8/9/14 </p> </td> <td> <p> 8/9/14 </p> </td> </tr> <tr> <td> <p> <b>Cynosure (US)</b> </p> </td> <td> <p> Ellman International (US) </p> </td> <td> <p> Aesthetic surgery </p> </td> <td> <p> $13.2m </p> </td> <td> <p> 8/9/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Veracyte (US)</b> </p> </td> <td> <p> Allegro Diagnostics (US) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> $21m </p> </td> <td> <p> 4/9/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Takara Bio (Japan)</b> </p> </td> <td> <p> Cellectis's Cellectis AB unit (France) </p> </td> <td> <p> Stem cell therapy </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cellulargenetic/Japanese-Takara-buys-Cellectis-stem-cell-unit-353725?autnID=/contentstore/clinica/codex/4b0258fb-34d9-11e4-ab26-2182f8e8159a.xml">4/9/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Avedro (US)</b> </p> </td> <td> <p> IROC Innocross (Switzerland) </p> </td> <td> <p> Ophthalmology </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 3/9/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Vygon (France)</b> </p> </td> <td> <p> Medwin (France) </p> </td> <td> <p> Feeding pumps and related accessories </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 2/9/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>August</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Rockwood Equity Partners (US)</b> </p> </td> <td> <p> Invacare's Altimate Medical business (US) </p> </td> <td> <p> Rehabilitation </p> </td> <td> <p> $23m </p> </td> <td> <p> 29/8/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Orgentech Diagnostika (Germany)</b> </p> </td> <td> <p> Corgenix Medical (US) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> $16m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Orgentec-expands-into-US-with-Corgenix-buy-353621?autnID=/contentstore/clinica/codex/ad6a25be-2f63-11e4-ab26-2182f8e8159a.xml">28/8/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Covidien (Ireland)</b> </p> </td> <td> <p> Sapheon (US) </p> </td> <td> <p> Cardiovascular (venous disease treatment) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Summer-buyin-happens-so-fast-Covidien-keeps-shopping-Alcon-eyes-WaveTec-353607?autnID=/contentstore/clinica/codex/974f178a-2ec7-11e4-ab26-2182f8e8159a.xml">28/8/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Alcon (US)</b> </p> </td> <td> <p> WaveTec Vision (US) </p> </td> <td> <p> Ophthalmology </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Summer-buyin-happens-so-fast-Covidien-keeps-shopping-Alcon-eyes-WaveTec-353607?autnID=/contentstore/clinica/codex/974f178a-2ec7-11e4-ab26-2182f8e8159a.xml">27/8/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Medtronic (US)</b> </p> </td> <td> <p> NGC Medical (Italy) </p> </td> <td> <p> Hospital service provider </p> </td> <td> <p> $350m for remaining 70% stake </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Medtronic-bolsters-Hospital-Solutions-biz-with-NGC-buy-353596?autnID=/contentstore/clinica/codex/a3eb0edb-2dec-11e4-ab26-2182f8e8159a.xml">27/8/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Medtronic (US)</b> </p> </td> <td> <p> Sapiens Steering Brain Stimulation (the Netherlands) </p> </td> <td> <p> Deep brain stimulation </p> </td> <td> <p> $200m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/neurological/Medtronic-and-Covidien-go-shopping-as-merger-nears-353564?autnID=/contentstore/clinica/codex/d85acfa6-2d24-11e4-ab26-2182f8e8159a.xml">26/8/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Elekta (Sweden)</b> </p> </td> <td> <p> RTA (Poland) </p> </td> <td> <p> Radiation therapy </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://http://www.clinica.co.uk/marketsector/other/Business-Bites-Elekta-expands-into-Poland-Endo-selling-off-AMS-353562?autnID=/contentstore/clinica/codex/2ee76a10-2d32-11e4-ab26-2182f8e8159a.xml">25/8/14</a> </p> </td> <td> <p> 17/3/15 </p> </td> </tr> <tr> <td> <p> <b>Covidien (Ireland)</b> </p> </td> <td> <p> Reverse Medical (US) </p> </td> <td> <p> Neurovascular and peripheral vascular devices </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/neurological/Medtronic-and-Covidien-go-shopping-as-merger-nears-353564?autnID=/contentstore/clinica/codex/d85acfa6-2d24-11e4-ab26-2182f8e8159a.xml">22/8/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>LeMaitre Vascular (US)</b> </p> </td> <td> <p> Xenotis (Australia) </p> </td> <td> <p> Peripheral bypass and dialysis access grafts </p> </td> <td> <p> $5.1m upfront, $1.4m milestones, $1.2m assumed debt </p> </td> <td> <p> 18/8/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Analytik Jena (Germany)</b> </p> </td> <td> <p> Bruker's ICP-MS business (US) </p> </td> <td> <p> Research </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 13/8/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>PDI's Interpace Diagnostics division (US)</b> </p> </td> <td> <p> Asuragen's miRInform Thyroid and Pancreas cancer tests (US) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 13/8/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Greatbatch (US)</b> </p> </td> <td> <p> CCC Medical Devices (Uruguay) </p> </td> <td> <p> OEM devices including pacemakers </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 12/8/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Global Life Safety Group (Canada)</b> </p> </td> <td> <p> Biosign Technologies' Pulsewave medical device line (Canada) </p> </td> <td> <p> Healthcare IT </p> </td> <td> <p> $1.8m </p> </td> <td> <p> 11/8/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Cerner (US)</b> </p> </td> <td> <p> Siemens' health information technology business unit, Siemens Health Services (US) </p> </td> <td> <p> Healthcare IT </p> </td> <td> <p> $1.3bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Siemens-sheds-health-IT-business-as-streamlining-continues-353217?autnID=/contentstore/clinica/codex/49de2ce9-1d4a-11e4-ab26-2182f8e8159a.xml">5/8/14 </a> </p> </td> <td> <p> 2/2/15 </p> </td> </tr> <tr> <td> <p> <b>Varian Medical Systems (US)</b> </p> </td> <td> <p> Certain assets of Transpire (US) including the Acuros dose calculation software </p> </td> <td> <p> Radiation simulation software </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 5/8/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Oxford Immunotec (UK)</b> </p> </td> <td> <p> Boulder Diagnostics (US) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> $1.8m upfront and up to $6.1m milestones </p> </td> <td> <p> 5/8/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Venn Life Sciences (the Netherlands)</b> </p> </td> <td> <p> Cardinal Systems (France) </p> </td> <td> <p> Clinical research organizations </p> </td> <td> <p> Share-based deal worth &euro;472,780 </p> </td> <td> <p> 5/8/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>ReproCELL (Japan)</b> </p> </td> <td> <p> BioServe Biotechnologies (US) </p> </td> <td> <p> Genomics services </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 4/8/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>ReproCELL (Japan)</b> </p> </td> <td> <p> Reinnervate (UK) </p> </td> <td> <p> 3D cell culture </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 4/8/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Tecomet (US)</b> </p> </td> <td> <p> Symmetry Medical's OEM Solutions business (US) </p> </td> <td> <p> Orthopedics </p> </td> <td> <p> $450m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Symmetry-offloads-OEM-business-to-Tecomet-forms-new-company-353200?autnID=/contentstore/clinica/codex/664e0b13-1c8b-11e4-ab26-2182f8e8159a.xml">4/8/14</a> </p> </td> <td> <p> 5/12/14 </p> </td> </tr> <tr> <td> <p> <b>Nordson (US)</b> </p> </td> <td> <p> Avalon Laboratories (US) </p> </td> <td> <p> Catheters and medical tubing products </p> </td> <td> <p> $180m </p> </td> <td> <p> 4/8/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>OHMK Medical Technology (China)</b> </p> </td> <td> <p> 29% stake in EnyMed (Israel) </p> </td> <td> <p> Aesthetics </p> </td> <td> <p> $7m </p> </td> <td> <p> 3/8/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Lubrizol (US)</b> </p> </td> <td> <p> Vesta (US) </p> </td> <td> <p> Medical device contract manufacturing </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 2/8/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>July</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Cura Healthcare (India)</b> </p> </td> <td> <p> DE Healthcare (India) </p> </td> <td> <p> Diagnostic imaging (ultrasound) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 31/7/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>3D Systems (US)</b> </p> </td> <td> <p> Simbionix (US) </p> </td> <td> <p> Surgical simulation </p> </td> <td> <p> $120m </p> </td> <td> <p> 30/7/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>SunTech Medical (US)</b> </p> </td> <td> <p> King&rsquo;s College London&rsquo;s central blood pressure technology and assets of Centron Diagnostics (UK) </p> </td> <td> <p> Cardiovascular (central blood pressure measurement) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 29/7/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Takara Bio (Japan)</b> </p> </td> <td> <p> Cellectis AB, stem cell subsidiary (France) </p> </td> <td> <p> Regenerative medicine </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 29/7/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Bruker (US)</b> </p> </td> <td> <p> Vutara (US) </p> </td> <td> <p> Life sciences (microscopy) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 28/7/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Medtronic (US)</b> </p> </td> <td> <p> Visualase (US) </p> </td> <td> <p> Surgery </p> </td> <td> <p> $70m upfront, up to $35m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Medtronic-splashes-up-to-105m-on-Visualase-expands-Lifetech-deal-353088">28/7/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Elekta (Sweden)</b> </p> </td> <td> <p> Mesi Medikal (Turkey) </p> </td> <td> <p> Radiation oncology </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 24/7/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Waters (US)</b> </p> </td> <td> <p> Rapid Evaporative Ionization Mass Spectrometry (REIMS) technology from MediMass (Hungary) </p> </td> <td> <p> Clinical diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 22/7/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Skanray Technologies (India)</b> </p> </td> <td> <p> Compagnia Elettronica Italiana (Italy) </p> </td> <td> <p> Diagnostic imaging (x-ray tubes) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 22/7/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Radnet (US)</b> </p> </td> <td> <p> Eight HealthCare Partners Medical Group facilities (US) </p> </td> <td> <p> Diagnostic imaging </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 18/7/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>GTCR (US)</b> </p> </td> <td> <p> Thermo Fisher Scientific's Cole-Parmer Instrument Company (US) </p> </td> <td> <p> Lab equipment, instruments and supplies </p> </td> <td> <p> $480m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Thermo-Fisher-offloads-Cole-Parmer-lab-products-biz-352939">17/7/14</a> </p> </td> <td> <p> 18/8/14 </p> </td> </tr> <tr> <td> <p> <b>Danaher (US)</b> </p> </td> <td> <p> Siemens' microbiology diagnostics unit (Germany) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> $450m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Danaher-swoops-for-Siemens-microbiology-diagnostics-unit-352923">17/7/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Illumina (US)</b> </p> </td> <td> <p> Myraqa (US) </p> </td> <td> <p> IVD and companion diagnostic consulting </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 16/7/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>iCAD (US) </b> </p> </td> <td> <p> DermEbx (US) <b> </b> </p> </td> <td> <p> Cancer (brachytherapy services)<b> </b> </p> </td> <td> <p> $12.6m for both DermEbx and Radion<b> </b> </p> </td> <td> <p> 15/7/14<b> </b> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>iCAD (US)</b> </p> </td> <td> <p> Radion (US) </p> </td> <td> <p> Cancer (cloud-based software) </p> </td> <td> <p> $12.6m for both DermEbx and Radion </p> </td> <td> <p> 15/7/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Mylan Laboratories (US)</b> </p> </td> <td> <p> Abbott's non-US developed markets specialty and branded generics business (the Netherlands) </p> </td> <td> <p> Generic drugs </p> </td> <td> <p> Stock deal worth $5.3bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Abbott-dumps-generic-drugs-business-looks-for-more-device-targets-352896">15/7/14</a> </p> </td> <td> <p> 27/2/15 </p> </td> </tr> <tr> <td> <p> <b>Ares Life Sciences (Switzerland)</b> </p> </td> <td> <p> Esaote (Italy) </p> </td> <td> <p> Diagnostic imaging </p> </td> <td> <p> &euro;19m for 8.2% stake (Aares now holds 48% of Esaote) </p> </td> <td> <p> 14/7/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>St Jude Medical (US)</b> </p> </td> <td> <p> NeuroTherm </p> </td> <td> <p> Spinal pain treatment </p> </td> <td> <p> $200m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/No-pain-more-gain-for-St-Jude-with-NeuroTherm-buy-352863">14/7/14</a> </p> </td> <td> <p> 7/8/14 </p> </td> </tr> <tr> <td> <p> <b>SomnoMed (Australia)</b> </p> </td> <td> <p> SSSleep lab di Martinez Ortodonzia (Italy) </p> </td> <td> <p> Dental sleep apnea </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 10/7/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>NeoGenomics (US)</b> </p> </td> <td> <p> Path Labs/ Path Logic (US) </p> </td> <td> <p> Diagnostics (pathology services) </p> </td> <td> <p> $6m </p> </td> <td> <p> 9/7/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>StoneCalibre (US)</b> </p> </td> <td> <p> Edge Biosystems (US) </p> </td> <td> <p> DNA sequencing (sample preparation products) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 8/7/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Mariel Therapeutics (US)</b> </p> </td> <td> <p> Stryker's Bone Morphogenetic Protein-7 (BMP-7) assets </p> </td> <td> <p> Orthopedics, kidney disaese, various other disorders </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Stryker-sells-BMP-products-to-Mariel-352705">7/7/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Thoma Bravo (US)</b> </p> </td> <td> <p> Sparta Systems (US) </p> </td> <td> <p> IT (quality management software) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 7/7/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Thoratec (US)</b> </p> </td> <td> <p> Apica Cardiovascular (Ireland) </p> </td> <td> <p> Cardiovascular (heart pumps) </p> </td> <td> <p> $35m upfront, up to $40m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Business-Bites-Thoratec-and-Abiomed-make-bolt-ons-T2-plans-69m-IPO-352651/">2/7/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Abiomed (US)</b> </p> </td> <td> <p> Aachen Innovative Solutions (Germany) </p> </td> <td> <p> Cardiovascular (heart pumps) </p> </td> <td> <p> $2.75m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Business-Bites-Thoratec-and-Abiomed-make-bolt-ons-T2-plans-69m-IPO-352651">2/7/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Abiomed (US)</b> </p> </td> <td> <p> Entwicklungsgesellschaft mbH (Germany) </p> </td> <td> <p> Cardiovascular (heart pumps) </p> </td> <td> <p> $13m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Business-Bites-Thoratec-and-Abiomed-make-bolt-ons-T2-plans-69m-IPO-352651">2/7/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Amplitude (France)</b> </p> </td> <td> <p> Continuum Lasers (US) </p> </td> <td> <p> Lasers for scientific, medical and industrial applications </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 1/7/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>June</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>The Cooper Companies (US)</b> </p> </td> <td> <p> Sauflon Pharmaceuticals (UK) </p> </td> <td> <p> Contact lenses and aftercare solutions </p> </td> <td> <p> $1.2bn </p> </td> <td> <p> 30/6/14 </p> </td> <td> <p> 6/8/14 </p> </td> </tr> <tr> <td> <p> <b>Stryker (US)</b> </p> </td> <td> <p> Small Bone Innovations (US) </p> </td> <td> <p> Orthopedics (extremities) </p> </td> <td> <p> $375m </p> </td> <td> <p> 30/6/14 </p> </td> <td> <p> 30/9/14 </p> </td> </tr> <tr> <td> <p> <b>iKang Healthcare Group (China)</b> </p> </td> <td> <p> Shanghai Huajian Clinic (China) - acquired remaining 67% stake </p> </td> <td> <p> Medical centers </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 30/6/14 </p> </td> <td> <p> 30/6/14 </p> </td> </tr> <tr> <td> <p> <b>Merz (Germany)</b> </p> </td> <td> <p> Ulthera (US) </p> </td> <td> <p> Aesthetics </p> </td> <td> <p> $600m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Merz-lifts-aesthetics-unit-with-600m-Ulthera-takeover-352578">26/6/14 </a> </p> </td> <td> <p> 29/7/14 </p> </td> </tr> <tr> <td> <p> <b>Owens &amp; Minor (US)</b> </p> </td> <td> <p> Medical Action Industries (US) </p> </td> <td> <p> Medical and surgical disposable products </p> </td> <td> <p> $208m </p> </td> <td> <p> 25/6/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Endomagnetics (UK)</b> </p> </td> <td> <p> Actium Biosystems' ACT portfolio (US) </p> </td> <td> <p> Heat therapy for cancer </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 24/6/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Cancer Genetics (US)</b> </p> </td> <td> <p> Gentris (US) </p> </td> <td> <p> Molecular diagnostics </p> </td> <td> <p> $4.75m upfront, up to $1.5m milestones </p> </td> <td> <p> 23/6/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Diagnostic Imaging International (US)</b> </p> </td> <td> <p> Unnamed mobile imaging company (US) </p> </td> <td> <p> Diagnostic imaging </p> </td> <td> <p> $3m </p> </td> <td> <p> 18/6/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>The Trendlines Group (Israel)</b> </p> </td> <td> <p> Intellectual property developed with Endo International (Ireland) </p> </td> <td> <p> Men&rsquo;s health, women&rsquo;s health and homecare </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 18/6/14 </p> </td> <td> <p> 18/6/14 </p> </td> </tr> <tr> <td> <p> <b>Schwarzer (Germany) </b> </p> </td> <td> <p> Cardiotek (the Netherlands)<b> </b> </p> </td> <td> <p> Cardiovascular (electrophysiology for monitoring)<b> </b> </p> </td> <td> <p> Undisclosed<b> </b> </p> </td> <td> <p> 18/6/14<b> </b> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Bio-Techne (US)</b> </p> </td> <td> <p> ProteinSimple (US) </p> </td> <td> <p> Protein analysis products for research </p> </td> <td> <p> $300m </p> </td> <td> <p> 17/6/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Hill-Rom Holdings (US)</b> </p> </td> <td> <p> TRUMPF Medical (Germany) </p> </td> <td> <p> Operating room infrastructure products </p> </td> <td> <p> $250m </p> </td> <td> <p> 16/6/14 </p> </td> <td> <p> 1/8/14 </p> </td> </tr> <tr> <td> <p> <b>Medtronic (US)</b> </p> </td> <td> <p> Covidien (Ireland) </p> </td> <td> <p> Endomechanical instruments, surgical supplies, soft tissue repair, vascular and monitoring </p> </td> <td> <p> $42.9bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/Medtronic-grabs-number-two-spot-and-new-tax-home-with-43bn-Covidien-buy-352353">15/6/14</a> </p> </td> <td> <p> 26/1/15 </p> </td> </tr> <tr> <td> <p> <b>Vialogy (US) </b> </p> </td> <td> <p> Premaitha (UK)<b> </b> </p> </td> <td> <p> Molecular diagnostics (prenatal screening)<b> </b> </p> </td> <td> <p> &pound;10.5m ($17.8m)<b> </b> </p> </td> <td> <p> 13/6/14<b> </b> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Medtronic (US)</b> </p> </td> <td> <p> Corventis (US) </p> </td> <td> <p> Cardiovascular (wireless continous cardiac monitoring) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Medtronic-confirms-Corventis-buy-gets-Infuse-boost-352245?autnID=/contentstore/clinica/codex/76aad9c8-f151-11e3-b761-d1c92b904d47.xml">5/6/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Henry Schein (US)</b> </p> </td> <td> <p> Sirona Direct, Sirona Dental Systems distribution business in France </p> </td> <td> <p> Dental </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 5/6/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Stentys (France)</b> </p> </td> <td> <p> Cappella Peel Away (US) </p> </td> <td> <p> Cardiology (stent delivery) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 5/6/14 </p> </td> <td> <p> 12/6/14 </p> </td> </tr> <tr> <td> <p> <b>Medytox Solutions (US)</b> </p> </td> <td> <p> Globalone Information Technologies (US) </p> </td> <td> <p> Healthcare IT (electronic health records) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 5/6/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Cantel Medical/</b> <b>Medivators (US)</b> </p> </td> <td> <p> PuriCore's UK endoscopy business (UK) </p> </td> <td> <p> Endoscopy </p> </td> <td> <p> $26.9m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Business-Bites-PuriCore-offloads-endoscopy-biz-Welch-Allyn-acquires-PediaVision-CareDx-targets-50m-IPO-352159">4/6/14</a> </p> </td> <td> <p> 1/7/14 </p> </td> </tr> <tr> <td> <p> <b>Welch Allyn (US)</b> </p> </td> <td> <p> PediaVision (US) </p> </td> <td> <p> Ophthalmology (vision assessment) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Business-Bites-PuriCore-offloads-endoscopy-biz-Welch-Allyn-acquires-PediaVision-CareDx-targets-50m-IPO-352159">3/6/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Immucor (US)</b> </p> </td> <td> <p> Organ-I (US) </p> </td> <td> <p> In vitro diagnostics for organ transplants </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 2/6/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Roche (Switzerland)</b> </p> </td> <td> <p> Genia (US) </p> </td> <td> <p> Molecular diagnostics (genome sequencing) </p> </td> <td> <p> $125m upfront, up to $225m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Roche-buys-disruptive-nanopore-genome-sequencing-tech-firm-Genia-352102/">2/6/14 </a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Symphony Technology Group (UK)</b> </p> </td> <td> <p> Several of the European healthcare technology operations of McKesson (US) </p> </td> <td> <p> Software/information technology </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 2/6/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Schurter (Switzerland)</b> </p> </td> <td> <p> Danielson (the Netherlands) </p> </td> <td> <p> Electronic components for medical device and other industries </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 2/6/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>May</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Agena Bioscience (US)</b> </p> </td> <td> <p> Sequenom's Bioscience business (US) </p> </td> <td> <p> Genetic analysis </p> </td> <td> <p> $31.8m upfront, up to $4m milestones </p> </td> <td> <p> 30/5/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>St Jude Medical (US)</b> </p> </td> <td> <p> Remaining 81% stake in CardioMEMS </p> </td> <td> <p> Cardiology (heart failure monitoring) </p> </td> <td> <p> $375m for 81% stake (plus $60m for 19% previously) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/St-Jude-to-acquire-CardioMEMS-after-heart-failure-monitor-clears-US-FDA-hurdle-352050">29/5/14</a> </p> </td> <td> <p> 2/6/14 </p> </td> </tr> <tr> <td> <p> <b>Volcano (US)</b> </p> </td> <td> <p> AtheroMed (US) </p> </td> <td> <p> Cardiovascular (atherectomy for peripheral arterial disease) </p> </td> <td> <p> $115m plus milestones </p> </td> <td> <p> <a href="Business-Bites-Spectranetics-and-Volcano-go-shopping-352024">28/5/14</a> </p> </td> <td> <p> 18/6/14 </p> </td> </tr> <tr> <td> <p> <b>Spectranetics (US)</b> </p> </td> <td> <p> AngioScore (US) </p> </td> <td> <p> Cardiovascular (balloon catheters) </p> </td> <td> <p> $230m plus milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Business-Bites-Spectranetics-and-Volcano-go-shopping-352024">28/5/14</a> </p> </td> <td> <p> 30/6/14 </p> </td> </tr> <tr> <td> <p> <b>Lab21 (UK)</b> </p> </td> <td> <p> Novacyt (France) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> Share-based reverse merger: Lab21 shareholders receive 2.5m Novacyt shares </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Lab21-gains-cervical-cancer-platform-with-Novacyt-merger-352006?autnID=/contentstore/clinica/codex/fec45d50-e28b-11e3-b761-d1c92b904d47.xml">27/5/14</a> </p> </td> <td> <p> 16/6/14 </p> </td> </tr> <tr> <td> <p> <b>HLD Corporation (US)</b> </p> </td> <td> <p> Symmetry Medical's Clamonta subsidiary (UK) </p> </td> <td> <p> Aerospace </p> </td> <td> <p> $1.3m </p> </td> <td> <p> 22/5/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>CareDx (US)</b> </p> </td> <td> <p> ImmuMetrix (US) </p> </td> <td> <p> In vitro diagnostics (transplant diagnostics) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 21/5/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Qiagen (the Netherlands)</b> </p> </td> <td> <p> Biobase (Germany) </p> </td> <td> <p> Bioinformatics (biological databases) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 20/5/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Cancer Genetics (US)</b> </p> </td> <td> <p> BioServe Biotechnologies (India) </p> </td> <td> <p> Diagnostics (genomics and next-generation genome sequencing) </p> </td> <td> <p> $1.9m in stock </p> </td> <td> <p> 15/5/14 </p> </td> <td> <p> 18/8/14 </p> </td> </tr> <tr> <td> <p> <b>Horizon Discovery Group (UK)</b> </p> </td> <td> <p> Zalicus's CombinatoRx services business (US) </p> </td> <td> <p> Drug discovery (high throughput screening) </p> </td> <td> <p> &pound;4.74m ($8.0m) </p> </td> <td> <p> 15/5/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Boston Scientific (US)</b> </p> </td> <td> <p> Bayer HealthCare's Medrad unit (Germany) </p> </td> <td> <p> Interventional devices </p> </td> <td> <p> $415m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Boston-sweeps-up-Bayers-interventional-devices-351847">15/5/14</a> </p> </td> <td> <p> 2/9/14 </p> </td> </tr> <tr> <td> <p> <b>PLC Systems (US)</b> </p> </td> <td> <p> Viveve (US) </p> </td> <td> <p> Women's health </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 14/5/14 </p> </td> <td> <p> 24/9/14 </p> </td> </tr> <tr> <td> <p> <b>Quintiles (US)</b> </p> </td> <td> <p> Encore Health Resources (US) </p> </td> <td> <p> Health information analytics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 12/5/14 </p> </td> <td> <p> 1/7/14 </p> </td> </tr> <tr> <td> <p> <b>Boston Scientific (US)</b> </p> </td> <td> <p> IoGyn (US) </p> </td> <td> <p> Women's health </p> </td> <td> <p> $65m for remaining 72% stake </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/legal/Business-Bites-BSX-grows-womens-health-unit-amid-OIG-scrutiny-STJ-MDT-grapple-with-investigations-litigation-351701">9/5/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Eurofins Scientific (Belgium)</b> </p> </td> <td> <p> ViraCor-IBT Laboratories (US) </p> </td> <td> <p> Molecular diagnostics </p> </td> <td> <p> $255m </p> </td> <td> <p> 9/5/14 </p> </td> <td> <p> 1/7/14 </p> </td> </tr> <tr> <td> <p> <b>Alliance HealthCare Services (US)</b> </p> </td> <td> <p> Vertical Health Solutions/ OnPoint Medical Diagnostics (US) </p> </td> <td> <p> Healthcare IT </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 6/5/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Z-Medica (US)</b> </p> </td> <td> <p> Taureon's Novacol product (the Netherlands) </p> </td> <td> <p> Wound care (resorbable hemostatic product) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 5/5/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Devicor Medical Products (US)</b> </p> </td> <td> <p> Biopsy Sciences' HydroMARK portfolio (US) </p> </td> <td> <p> Breast biopsy markers </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 1/5/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>April</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Groupe GorgÃ© (France)</b> </p> </td> <td> <p> DeltaMed (Germany) </p> </td> <td> <p> 3D printing materials </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 28/4/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Novadaq Technologies (Canada)</b> </p> </td> <td> <p> A&iuml;mago (Swizterland) </p> </td> <td> <p> Diagnostic imaging (skin perfusion imaging) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 24/4/14 </p> </td> <td> <p> 13/5/14 </p> </td> </tr> <tr> <td> <p> <b>Zimmer (US)</b> </p> </td> <td> <p> Biomet (US) </p> </td> <td> <p> Orthopedics </p> </td> <td> <p> $13.35bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Zimmer-in-frame-for-number-two-ortho-spot-with-13bn-Biomet-buy-351443">24/4/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Aastrom Biosciences (US)</b> </p> </td> <td> <p> Sanofi's Cell Therapy and Regenerative Medicine business (France) </p> </td> <td> <p> Regenerative medicine </p> </td> <td> <p> $6.5m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cellulargenetic/Aastrom-buys-Sanofis-cell-therapy-biz-for-6.5m-351401?autnID=/contentstore/clinica/codex/3f661ea0-ca23-11e3-9744-2d401cb09751.xml">21/4/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>OPKO Health (US)</b> </p> </td> <td> <p> Inspiro Medical (Israel) </p> </td> <td> <p> Drug delivery (inhalers) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 17/4/14 </p> </td> <td> <p> 22/5/14 </p> </td> </tr> <tr> <td> <p> <b>Medline Industries (US)</b> </p> </td> <td> <p> Amendia's anterior cervical fusion distraction pin business (US) </p> </td> <td> <p> Orthopedics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 16/4/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Mesa Laboratories (US)</b> </p> </td> <td> <p> BGI Instruments and BGI (US) </p> </td> <td> <p> Flow measurement for industrial and envinronmental monitoring </p> </td> <td> <p> $9.9m </p> </td> <td> <p> 15/4/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>NeoStem (US)</b> </p> </td> <td> <p> California Stem Cell (US) </p> </td> <td> <p> Regenerative medicine </p> </td> <td> <p> 5.33 million NeoStem shares; up to $90m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cellulargenetic/NeoStem-to-buy-California-stem-cell-351398?autnID=/contentstore/clinica/codex/3d8f29d9-ca00-11e3-9744-2d401cb09751.xml">14/4/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>BioProspect (Australia)</b> </p> </td> <td> <p> Invatec/Heartlink's heart rate variability index technology </p> </td> <td> <p> Mental health test </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 14/4/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Covidien (Ireland)</b> </p> </td> <td> <p> New Wave Surgical (US) </p> </td> <td> <p> Surgery (laparoendoscopic devices) </p> </td> <td> <p> Reportedly $100m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Covidien-boosts-endoscopy-offering-with-New-Wave-while-recall-hits-sales-351288">14/4/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Bio-Rad Laboratories (US) </b> </p> </td> <td> <p> GnuBIO (US)<b> </b> </p> </td> <td> <p> Molecular diagnostics (DNA sequencing)<b> </b> </p> </td> <td> <p> Undisclosed<b> </b> </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Bio-Rad-gets-new-DNA-sequencing-offering-with-GnuBIO-buy-351222">10/4/14</a> <b> </b> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Medtronic (US)</b> </p> </td> <td> <p> Majority stake in Biostar (Turkey) </p> </td> <td> <p> Distribution (CRM, atrial fibrillation, structural heart and renal denervation products) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/funding/Medtronics-investments-will-go-up-not-down-says-business-development-exec-351219">7/4/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Roche (Switzerland)</b> </p> </td> <td> <p> IQuum (US) </p> </td> <td> <p> Point-of-care molecular diagnostics </p> </td> <td> <p> $275m upfront, $175m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Roche-steps-into-point-of-care-molecular-diagnostics-with-IQuum-buy-351136">7/4/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Physician's Choice Laboratory Services (US)</b> </p> </td> <td> <p> MultiGEN Diagnostics (US) </p> </td> <td> <p> Molecular diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 7/4/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Mesa Laboratories (US)</b> </p> </td> <td> <p> Amilabo (France) </p> </td> <td> <p> Biological indicators for checking sterilization </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 4/4/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Cardinal Health (US)</b> </p> </td> <td> <p> AccessClosure (US) </p> </td> <td> <p> Cardiology (extravascular closure devices) </p> </td> <td> <p> $320m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/Business-bites-Cardinal-Health-buys-vascular-closure-firm-more-IPOs-351094?autnID=/contentstore/clinica/codex/93ac9885-bc0f-11e3-a09b-cf70e6dc602b.xml">2/4/14</a> </p> </td> <td> <p> 12/5/14 </p> </td> </tr> <tr> <td> <p> <b>GE Healthcare (UK)</b> </p> </td> <td> <p> CHCA Computer Systems (Canada) </p> </td> <td> <p> IT solutions for operating room management and analytics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Business-bites-Double-deal-in-OR-space-as-GE-buys-CHCA-and-Steris-bags-IMS-351031">2/4/14</a> </p> </td> <td> <p> 15/4/14 </p> </td> </tr> <tr> <td> <p> <b>Steris (US)</b> </p> </td> <td> <p> Integrated Medical Systems International (US) </p> </td> <td> <p> Surgery (endoscope repair, surgical instrument management and clinical consulting) </p> </td> <td> <p> $165m, plus $10m for the purchase of real estate </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Business-bites-Double-deal-in-OR-space-as-GE-buys-CHCA-and-Steris-bags-IMS-351031">1/4/14</a> </p> </td> <td> <p> 14/5/14 </p> </td> </tr> <tr> <td> <p> <b>March</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Covidien (Ireland)</b> </p> </td> <td> <p> Zephyr Technology (US) </p> </td> <td> <p> Patient monitoring </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> March 2014 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>ICON (Ireland)</b> </p> </td> <td> <p> Aptiv Solutions (US) </p> </td> <td> <p> Software for clinical trials </p> </td> <td> <p> $143.5m </p> </td> <td> <p> 31/3/14 </p> </td> <td> <p> 8/5/14 </p> </td> </tr> <tr> <td> <p> <b>Sterigenics (US)</b> </p> </td> <td> <p> Nordion (Canada) </p> </td> <td> <p> Sterilization and medical isotopes </p> </td> <td> <p> $727m (increased to $805m on 2/6/14) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Clean-start-for-Nordion-Sterigenics-shells-out-727m-350952">31/3/14</a> </p> </td> <td> <p> 6/8/14 </p> </td> </tr> <tr> <td> <p> <b>AirStrip (US)</b> </p> </td> <td> <p> Sense4Baby (US) </p> </td> <td> <p> Wireless fetal/maternal monitoring </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 27/3/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>North Coast Medical (US)</b> </p> </td> <td> <p> ActivaTek (US) </p> </td> <td> <p> Drug delivery for anti-inflammation and pain management </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 25/3/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>MGC Diagnostics (US)</b> </p> </td> <td> <p> Medisoft (Belgium) </p> </td> <td> <p> Cardio-respiratory diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 20/3/14 </p> </td> <td> <p> 1/8/14 </p> </td> </tr> <tr> <td> <p> <b>EKF Diagnostics (UK)</b> </p> </td> <td> <p> DiaSpect Medical (Sweden) </p> </td> <td> <p> In vitro diagnostics (point-of-care hemoglobin testing) </p> </td> <td> <p> &pound;10.25m in cash and &pound;5.75m in shares up front, up to &pound;4.75m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/EKF-bulks-up-with-two-deals-bioMerieux-considering-Siemens-swoop-350785?autnID=/contentstore/clinica/codex/aa3335b8-b028-11e3-a09b-cf70e6dc602b.xml">20/3/14</a> </p> </td> <td> <p> 22/4/14 </p> </td> </tr> <tr> <td> <p> <b>EKF Diagnostics (UK)</b> </p> </td> <td> <p> Selah Genomics (US) </p> </td> <td> <p> Molecular diagnostics </p> </td> <td> <p> $35.6m in shares up front, up to $35.0m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/EKF-bulks-up-with-two-deals-bioMerieux-considering-Siemens-swoop-350785?autnID=/contentstore/clinica/codex/aa3335b8-b028-11e3-a09b-cf70e6dc602b.xml">20/3/14</a> </p> </td> <td> <p> 22/4/14 </p> </td> </tr> <tr> <td> <p> <b>Sparton (US)</b> </p> </td> <td> <p> Aubrey Group (US) </p> </td> <td> <p> OEM products </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 18/3/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Sorin (Italy)</b> </p> </td> <td> <p> Oscor&rsquo;s lead business (US) </p> </td> <td> <p> Cardiovascular (cardiac leads) </p> </td> <td> <p> $20m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Sorin-strengthens-lead-business-as-financial-shockwaves-recede-350760?autnID=/contentstore/clinica/codex/46a47f3a-aea1-11e3-a09b-cf70e6dc602b.xml">18/3/14 </a> </p> </td> <td> <p> 18/3/14 </p> </td> </tr> <tr> <td> <p> <b>Unnamed private equity firm</b> </p> </td> <td> <p> IBA's PharmaLogic PET Services (Canada) </p> </td> <td> <p> Molecular imaging </p> </td> <td> <p> &euro;7.7m ($10.6m) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/IBA-casts-off-final-non-core-assets-to-hone-proton-therapy-focus-350813">17/3/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Digirad (US)</b> </p> </td> <td> <p> Telerhythmics (US) </p> </td> <td> <p> Cardiology (cardiac event monitoring service) </p> </td> <td> <p> $3.6m </p> </td> <td> <p> 14/3/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Varian Medical Systems (US)</b> </p> </td> <td> <p> Certain assets of Velocity Medical Solutions (US) </p> </td> <td> <p> Imaging software </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 12/3/14 </p> </td> <td> <p> 4/4/14 </p> </td> </tr> <tr> <td> <p> <b>EKF Diagnostics (UK)</b> </p> </td> <td> <p> Separation Technlogy (US) </p> </td> <td> <p> In vitro diagnostics (hematology testing) </p> </td> <td> <p> $4.0m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Business-Bites-Quest-makes-second-buy-of-year-EKF-boosts-hematology-portfolio-350599">12/3/14</a> </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Business-Bites-Quest-makes-second-buy-of-year-EKF-boosts-hematology-portfolio-350599">12/3/14</a> </p> </td> </tr> <tr> <td> <p> <b>Quest Diagnostics (US)</b> </p> </td> <td> <p> Summit Health (US) </p> </td> <td> <p> Disease prevention and wellness programs </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Business-Bites-Quest-makes-second-buy-of-year-EKF-boosts-hematology-portfolio-350599">11/3/14 </a> </p> </td> <td> <p> 21/4/14 </p> </td> </tr> <tr> <td> <p> <b>Thoma Bravo (US)</b> </p> </td> <td> <p> Global Healthcare Exchange (US) </p> </td> <td> <p> Healthcare supply chain software </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 11/3/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>The Gores Group and Technology4Medicine (US)</b> </p> </td> <td> <p> Fotona (Slovenia) </p> </td> <td> <p> Medical lasers </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 6/3/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Retroscreen Virology Group (UK)</b> </p> </td> <td> <p> Activiomics (UK) </p> </td> <td> <p> In vitro diagnostics (proteomics) </p> </td> <td> <p> Up to &pound;4m ($6.7m) </p> </td> <td> <p> 4/3/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Oxford Gene Technology (OGT, UK)</b> </p> </td> <td> <p> Cytocell (UK) </p> </td> <td> <p> Molecular diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/OGT-goes-FISHing-with-Cytocell-buy-350369">4/3/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Advanced Accelerator Applications (France)</b> </p> </td> <td> <p> Imaging Equipment (UK) </p> </td> <td> <p> Diagnostic imaging (imaging agents) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/AAA-buys-into-UK-but-US-the-big-prize-350364">4/3/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>February</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Laboratory Corporation of America (LabCorp, US)</b> </p> </td> <td> <p> Covance's high-complexity genomic laboratory (US) </p> </td> <td> <p> In vitro diagnostics (genetic testing) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 25/2/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Syneron Medical (Israel)</b> </p> </td> <td> <p> New Star Lasers aka CoolTouch (US) </p> </td> <td> <p> Lasers (medical and aesthetic) </p> </td> <td> <p> $11m </p> </td> <td> <p> 20/2/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>LifeLabs Medical Laboratory Services (Canada)</b> </p> </td> <td> <p> Centogene's (Germany) Canadian business </p> </td> <td> <p> In vitro diagnostics (genetic testing) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 19/2/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Stryker (US)</b> </p> </td> <td> <p> Pivot Medical (US) </p> </td> <td> <p> Orthopedic (hip restoration) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Business-Bites-Stryker-gets-hip-new-offering-Medtronics-not-so-big-Reveal-350158?autnID=/contentstore/clinica/codex/5d10fa89-9a33-11e3-a09b-cf70e6dc602b.xml">19/2/14</a> </p> </td> <td> <p> 7/3/14 </p> </td> </tr> <tr> <td> <p> <b>Stryker (US)</b> </p> </td> <td> <p> Berchtold (Germany) </p> </td> <td> <p> Surgery (infrastructure equipment) </p> </td> <td> <p> $172m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Business-Bites-Stryker-buys-Berchtold-to-bolt-on-surgical-equipment-350125?autnID=/contentstore/clinica/codex/f5ccf733-995f-11e3-a09b-cf70e6dc602b.xml">18/2/14</a> </p> </td> <td> <p> 15/4/14 </p> </td> </tr> <tr> <td> <p> <b>GSI Group (US)</b> </p> </td> <td> <p> Jadak (US) </p> </td> <td> <p> OEM components </p> </td> <td> <p> $93.5m </p> </td> <td> <p> 18/2/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>TearLab (US)</b> </p> </td> <td> <p> AOAExcel's OcuHub Business (US) </p> </td> <td> <p> Healthcare IT </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Business-Bites-Stryker-buys-Berchtold-to-bolt-on-surgical-equipment-350125?autnID=/contentstore/clinica/codex/f5ccf733-995f-11e3-a09b-cf70e6dc602b.xml">18/2/14</a> </p> </td> <td> <p> 14/3/14 </p> </td> </tr> <tr> <td> <p> <b>PhotoMedex (US)</b> </p> </td> <td> <p> LCA-Vision (US) </p> </td> <td> <p> Ophthalmology (laser vision correction) </p> </td> <td> <p> $106.4m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Business-Bites-Abbott-Baxter-touted-as-buyers-for-Danones-medical-nutrition-unit-350057?autnID=/contentstore/clinica/codex/2393dae5-9588-11e3-a09b-cf70e6dc602b.xml">14/2/14 </a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Fluke Biomedical (US)</b> </p> </td> <td> <p> Unfors RaySafe (Sweden) </p> </td> <td> <p> Diagnostic imaging (X-rays) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 5/2/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>PBM Capital (US)</b> </p> </td> <td> <p> GE Healthcare's Breas Medical business (Sweden) </p> </td> <td> <p> Home healthcare </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 4/2/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Myriad Genetics (US)</b> </p> </td> <td> <p> Crescendo Bioscience (US) </p> </td> <td> <p> In vitro diagnostics (autoimmune tests) </p> </td> <td> <p> $270m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/RESULTS-ROUND-UP-Boston-turnaround-sputtering-Myriad-makes-mockery-of-analyst-forecasts-349828">4/2/14</a> </p> </td> <td> <p> 28/2/14 </p> </td> </tr> <tr> <td> <p> <b>Bioventus (US)</b> </p> </td> <td> <p> Galderma's Durolane assets (Switzerland) </p> </td> <td> <p> Orthopedics (joint fluid injection for osteoarthritis) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 4/2/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Montagu Private Equity (UK)</b> </p> </td> <td> <p> Rexam's healthcare business (UK) </p> </td> <td> <p> Drug delivery </p> </td> <td> <p> $805m </p> </td> <td> <p> 3/2/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Accellent (US)</b> </p> </td> <td> <p> Lake Region Medical (US) </p> </td> <td> <p> Cardiology and endovascular OEM devices and delivery systems </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 3/2/14 </p> </td> <td> <p> 12/3/14 </p> </td> </tr> <tr> <td> <p> <b>Medline Industries (US)</b> </p> </td> <td> <p> Professional Hospital Supply (US) </p> </td> <td> <p> Medical and surgical supplies distribution </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 3/2/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Sorin (Italy)</b> </p> </td> <td> <p> Bioengineering Laboratories' cardiac surgery cannulae manufacturing activities (Italy) </p> </td> <td> <p> Cardiac surgery </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 3/2/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Smith &amp; Nephew (UK)</b> </p> </td> <td> <p> ArthroCare (US) </p> </td> <td> <p> Orthopedics (sports medicine), ENT </p> </td> <td> <p> $1.7bn </p> </td> <td> <p> <a href="http://http://www.clinica.co.uk/marketsector/orthopaedics/SandN-continues-diversification-with-1.7bn-ArthroCare-buy-349760">3/2/14</a> </p> </td> <td> <p> 29/5/14 </p> </td> </tr> <tr> <td> <p> <b>January</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Physio-Control (US)</b> </p> </td> <td> <p> Sansio (US) </p> </td> <td> <p> Healthcare IT </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 31/1/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Wright Medical (US)</b> </p> </td> <td> <p> OrthoPro (US) </p> </td> <td> <p> Orthopedics (extremities) </p> </td> <td> <p> $32.5m upfront, $3.5m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Wright-goes-to-further-extremes-with-two-more-buys-349735">31/1/14</a> </p> </td> <td> <p> 6/2/14 </p> </td> </tr> <tr> <td> <p> <b>Wright Medical (US)</b> </p> </td> <td> <p> Solana Surgical (US) </p> </td> <td> <p> Orthopedics (extremities) </p> </td> <td> <p> $90m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Wright-goes-to-further-extremes-with-two-more-buys-349735">31/1/14</a> </p> </td> <td> <p> 31/1/14 </p> </td> </tr> <tr> <td> <p> <b>Fluidigm (US)</b> </p> </td> <td> <p> DVS Sciences (US) </p> </td> <td> <p> Research/diagnostics (mass cytometry for protein analysis) </p> </td> <td> <p> $207.5m </p> </td> <td> <p> 29/1/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>LifeCell (US)</b> </p> </td> <td> <p> TauTona's advanced adipose tissue injector (US) </p> </td> <td> <p> Aesthetic and reconstructive surgery </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 27/1/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Collbio (UK)</b> </p> </td> <td> <p> Collagen Solutions (US) </p> </td> <td> <p> Biomaterials </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 27/1/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>IP Group (UK)</b> </p> </td> <td> <p> Fusion IP (UK) </p> </td> <td> <p> University intellectual property </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 24/1/14 </p> </td> <td> <p> 20/3/14 </p> </td> </tr> <tr> <td> <p> <b>Pharmacell (the Netherlands)</b> </p> </td> <td> <p> TiGenix's (Belgium) Dutch production facility </p> </td> <td> <p> Regenerative medicine </p> </td> <td> <p> &euro;5.75m ($7.9m) </p> </td> <td> <p> 24/1/14 </p> </td> <td> <p> 2/6/14 </p> </td> </tr> <tr> <td> <p> <b>Arkray (Japan)</b> </p> </td> <td> <p> Span Diagnostics (India) </p> </td> <td> <p> In vitro diagnostics (test reagents) </p> </td> <td> <p> 734m rupees ($11.6m) </p> </td> <td> <p> 24/1/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>SCL Health System (US) and Univita Health (US)</b> </p> </td> <td> <p> All Care Home Health (US) </p> </td> <td> <p> Home healthcare </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 23/1/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Quest Diagnostics (US)</b> </p> </td> <td> <p> Solstas Lab Partners (US) </p> </td> <td> <p> In vitro diagnostics (lab services) </p> </td> <td> <p> $570m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Quest-loses-no-momentum-in-lab-expansion-plans-349553">23/1/14</a> </p> </td> <td> <p> 10/3/14 </p> </td> </tr> <tr> <td> <p> <b>Teva Pharmaceuticals (Israel)</b> </p> </td> <td> <p> NuPathe (US) </p> </td> <td> <p> Drug delivery (migraine patch) </p> </td> <td> <p> $144m plus milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Teva-nabs-migraine-patch-maker-NuPathe-for-144m-undoing-Endo-deal-349510">22/1/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Intuitive Surgical (US)</b> </p> </td> <td> <p> Luna Innovations' shape-sensing technology (US) </p> </td> <td> <p> Robotic surgery </p> </td> <td> <p> $12m upfront, up to $18m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Q4-EARNINGS-Intuitive-shares-slump-as-sales-dip-349611?autnID=/contentstore/clinica/codex/7745c422-876e-11e3-a09b-cf70e6dc602b.xml">22/1/14</a> </p> </td> <td> <p> 25/4/14 </p> </td> </tr> <tr> <td> <p> <b>Organogenesis (US)</b> </p> </td> <td> <p> Shire's Dermagraft assets (US) </p> </td> <td> <p> Regenerative medicine/ wound healing </p> </td> <td> <p> No upfront payment, up to $300m milestones </p> </td> <td> <p> 17/1/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>The Carlyle Group (US)</b> </p> </td> <td> <p> Johnson &amp; Johnson's Ortho-Clinical Diagnostics unit (US) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> $4.15bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Private-equity-firm-Carlyle-bags-JnJs-Ortho-diagnostic-unit-349411">17/1/14</a> </p> </td> <td> <p> 30/6/14 </p> </td> </tr> <tr> <td> <p> <b>AkesoGenX (US)</b> </p> </td> <td> <p> Therm Med's Kanzius Cancer Treatment technology (US) </p> </td> <td> <p> Nanotechnology (noninvasive cancer treatment) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 17/1/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Carl Zeiss Meditec (Germany)</b> </p> </td> <td> <p> Aaren Scientific (US) </p> </td> <td> <p> Ophthalmology (intraocular lenses) </p> </td> <td> <p> $70m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Carl-Zeiss-broadens-intraocular-lens-offering-with-70m-Aaren-purchase-349326">14/1/14 </a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Altaris Capital Partners (US)</b> </p> </td> <td> <p> Remainder of Endo Health Solutions' HealthTronics urology business (US) </p> </td> <td> <p> Urology </p> </td> <td> <p> $85m upfront, up to $45m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Endo-sells-remaining-HealthTronics-unit-349327">14/1/14</a> </p> </td> <td> <p> 3/2/14 </p> </td> </tr> <tr> <td> <p> <b>Covidien (Ireland)</b> </p> </td> <td> <p> Changzhou Kangdi Medical Stapler (China) </p> </td> <td> <p> Surgery (open stapler products) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 13/1/14 </p> </td> <td> <p> 13/1/14 </p> </td> </tr> <tr> <td> <p> <b>Covidien (Ireland)</b> </p> </td> <td> <p> WEM Equipamentos Eletr&ocirc;nicos (Brazil) </p> </td> <td> <p> Surgery (electrosurgical generators, disposables and accessories) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 13/1/14 </p> </td> <td> <p> 13/1/14 </p> </td> </tr> <tr> <td> <p> <b>Vocera Communications (US)</b> </p> </td> <td> <p> mVisum (US) </p> </td> <td> <p> Medical alarms </p> </td> <td> <p> $3.5m </p> </td> <td> <p> 13/1/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>CytoCore (US)</b> </p> </td> <td> <p> Medite (US) </p> </td> <td> <p> Tissue diagnostics (lab automation eqipment and supplies for pathology, histology and cytology) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 13/1/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Millennium Laboratories (US)</b> </p> </td> <td> <p> RxAnte (US) </p> </td> <td> <p> Healthcare analytics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 13/1/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Globus Medical (US)</b> </p> </td> <td> <p> Excelsius Surgical (US) </p> </td> <td> <p> Robotic surgery </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Globus-gets-in-on-robotic-surgery-with-Excelsius-buy-349202?autnID=/contentstore/clinica/codex/dbb26e06-7938-11e3-8f73-257c4a8c1054.xml">9/1/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Cantel Medical (US)</b> </p> </td> <td> <p> Sterilator (US) </p> </td> <td> <p> Sterilization monitoring products </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 8/1/14 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Becton Dickinson (US)</b> </p> </td> <td> <p> Alverix (US) </p> </td> <td> <p> Point-of-care diagnostics </p> </td> <td> <p> $40m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Becton-Dickinson-expands-point-of-care-offering-with-Alverix-buy-349164?autnID=/contentstore/clinica/codex/900b7479-7860-11e3-8f73-257c4a8c1054.xml">8/1/14</a> </p> </td> <td> <p> 8/1/14 </p> </td> </tr> <tr> <td> <p> <b>GE Healthcare (UK)</b> </p> </td> <td> <p> Finnamore (UK) </p> </td> <td> <p> Health and social care consultancy </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/policyregulation/GE-Healthcare-extends-reach-of-healthcare-consultancy-arm-349230?autnID=/contentstore/clinica/codex/a40420a7-79cc-11e3-8f73-257c4a8c1054.xml">8/1/14</a> </p> </td> <td> <p> 8/1/14 </p> </td> </tr> <tr> <td> <p> <b>Philips (the Netherlands)</b> </p> </td> <td> <p> Aerogen's range of home nebulizers (Ireland) </p> </td> <td> <p> Home care (respiratory drug delivery) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://http://www.clinica.co.uk/marketsector/other/Philips-boosts-home-health-offering-with-Aerogen-nebulizer-buy-349143?autnID=/contentstore/clinica/codex/194b7a41-77a6-11e3-8f73-257c4a8c1054.xml">7/1/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Medtronic (US)</b> </p> </td> <td> <p> TYRX (US) </p> </td> <td> <p> Drug-device products for implanted medical devices </p> </td> <td> <p> $160m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Medtronic-gains-implanted-device-anti-infection-tech-with-TYRX-buy-349142?autnID=/contentstore/clinica/codex/83cc344c-7794-11e3-8f73-257c4a8c1054.xml">7/1/14</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Henry Schein (US)</b> </p> </td> <td> <p> Arseus's dental distribution, lab and software businesses (Belgium/the Netherlands) </p> </td> <td> <p> Dental </p> </td> <td> <p> &euro;50m ($68m) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Henry-Schein-bulks-up-again-with-Arseus-dental-buy-349130?autnID=/contentstore/clinica/codex/fe0980a3-7788-11e3-8f73-257c4a8c1054.xml">7/1/14</a> </p> </td> <td> <p> 7/1/14 </p> </td> </tr> <tr> <td> <p> <b>GE Healthcare (UK)</b> </p> </td> <td> <p> Thermo Fisher Scientific's HyClone cell culture media and sera, gene modulation and magnetic beads businesses (US) </p> </td> <td> <p> Drug discovery and manufacture </p> </td> <td> <p> $1.06bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Thermo-Fisher-closer-to-Life-offloading-units-to-GE-349118?autnID=/contentstore/clinica/codex/73b9ca9f-76e9-11e3-8f73-257c4a8c1054.xml">6/1/14</a> </p> </td> <td> <p> 24/3/14 </p> </td> </tr> <tr> <td> <p> <b>Carl Zeiss Meditec (Germany)</b> </p> </td> <td> <p> Optronik (Turkey) </p> </td> <td> <p> Ophthalmology </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 3/1/14 </p> </td> <td> <p> 3/1/14 </p> </td> </tr> </table> <p> <a href="http://www.clinica.co.uk/multimedia/archive/00248/M_A_2014_248634a.zip">Download the Excel table here</a> </p> 
----field----
field: {0212FC0F-953B-461C-B4D9-B7483A4D4F1B}
name: Taxonomy
key: taxonomy
content-length: 38

{2EDCC1FF-26E4-4C6E-AF73-0F43F0F033B8}
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 29

Mergers and Acquisitions 2014
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

20160622T191355
----field----
field: {1616FE67-7278-4169-948E-C29B00EC8781}
name: Article Number
key: article number
content-length: 8

MT062758
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 29

Mergers and Acquisitions 2014
----field----
field: {0F6C8F42-01DC-4E05-B63E-AA25D8AA0E09}
name: Legacy Publication
key: legacy publication
content-length: 38

{FF38DC83-07D4-43F0-8C55-84EB64FAF35A}
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 6

349291
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160622T192229Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 18

sitecore\Anonymous
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

5eba67ac-6f37-477c-959d-75fa3a463391
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160622T231355Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 14

sitecore\admin
----field----
field: {3E431DE1-525E-47A3-B6B0-1CCBEC3A8C98}
name: __Workflow state
key: __workflow state
content-length: 38

{962542F5-554E-4DE8-BE4C-B0796FDAC854}
